Xeljanz 5 MG tablet UU 60S
Ended Awarded
- Contract number
- SPE2DB25FN3ZE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,639
Award facts
- Contract value 100% obligated
- $24,639.34 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $24,639.34 to AmerisourceBergen Drug Corp for the supply of 60 units of Xeljanz 5 mg tablets. This competitive award, issued on August 22, 2025, with an ultimate completion date of August 25, 2025, utilizes firm fixed pricing and carries no set-aside designation. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a child contract under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle that runs through December 2026.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal healthcare vendor that supplies a comprehensive range of medications and medical supplies to support military and veteran healthcare systems. The company maintains an extensive portfolio of federal contracts with the Defense Logistics Agency's Medical Supply Chain, delivering pharmaceutical products across multiple therapeutic domains including specialty medications, brand-name and generic drugs, and vaccines. The DLA Troop Support Medical contract serves as a flexible procurement vehicle enabling AmerisourceBergen to supply products to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, with the agency planning to transition to Pharmaceutical Prime Vendor Global Program Generation V contracts in the coming years that will involve multiple regional awards.
Quick answers
Who was awarded contract SPE2DB25FN3ZE?
SPE2DB25FN3ZE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 22, 2025.
How much is contract SPE2DB25FN3ZE worth?
The government has obligated $24,639 on SPE2DB25FN3ZE.
Is contract SPE2DB25FN3ZE an order under another contract?
Yes. SPE2DB25FN3ZE is a delivery order under SPE2DB22D1200, an indefinite delivery contract.
Was contract SPE2DB25FN3ZE competed?
The extent of competition for SPE2DB25FN3ZE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award